We have extensive experience in the development of anti-cancer agents, including the use of in vitro anti-cancer assays involving a wide variety of cancer cell lines, as well as the use of relevant animal models such as murine xenograft models and the hollow fiber implantation model. Our assay development expertise allows for the derivation of novel assays to explore a wide variety of molecular anti-cancer targets using our knowledge of cancer cell biology.